Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation

OBJECTIVE: During the first wave of the SARS-CoV-2 pandemic, management of anticoagulation therapy in hospitalized patients with atrial fibrillation (AF) was simplified to low-molecular-weight heparin (LMWH) followed by oral anticoagulation, mainly owing to the risk of drug–drug interactions. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivera, Pável, Velásquez-Escandón, César, Campoy, Desirée, Flores, Katia, Canals, Tania, Johansson, Erik, Herranz, María José, Martínez, Laia, Cerezo-Manchado, Juan José, Salinas, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259115/
https://www.ncbi.nlm.nih.gov/pubmed/37282505
http://dx.doi.org/10.1177/10760296231180865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259115/
https://www.ncbi.nlm.nih.gov/pubmed/37282505
http://dx.doi.org/10.1177/10760296231180865

Ejemplares similares